RANDOMISED CONTROLLED TRIAL OF ARIPIPRAZOLE FOR TREATMENT OF AUDITORY VERBAL HALLUCINATIONS IN BORDERLINE PERSONALITY DISORDER
Grant number: 1102595 | Funding period: 2016 - 2021
People with borderline personality disorder (BPD) often report hearing voices. There is no consensus about how to treat these symptoms. Our study aims to address this clinical problem by conducting a 12 week trial of antipsychotic medication in patients who hear voices and have a diagnosis of BPD. The study will examine the effect of this medication on the nature of these voices, as well as other aspects of mental illness and brain functioning. The results will directly inform clinical practice.
Related publications (2)
Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial
Andrew M Chanen, Jennifer Betts, Henry Jackson, Patrick McGorry, Barnaby Nelson, Sue M Cotton, Cali Bartholomeusz, Martina Jovev, Aswin Ratheesh, Christopher Davey, Christos Pantelis, Louise McCutcheon, Shona Francey, Amit Bhaduri, Danielle Lowe, Victoria Rayner, Katherine Thompson
AIM: Up to half of patients with borderline personality disorder report auditory verbal hallucinations that are phenomenologically..
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol
Amber Weller, John Gleeson, Mario Alvarez-Jimenez, Patrick McGorry, Barnaby Nelson, Kelly Allott, Sarah Bendall, Cali Bartholomeusz, Peter Koval, Susy Harrigan, Brian O'Donoghue, Alex Fornito, Christos Pantelis, G Paul Amminger, Aswin Ratheesh, Andrea Polari, Stephen J Wood, Kristi van der El, Carli Ellinghaus, Jesse Gates
Antipsychotic medication has been the mainstay of treatment for psychotic illnesses for over 60 years. This has been associated wi..